OrbiMed Advisors »

Celcuity shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Celcuity shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Celcuity

Tip: Access up to 7 years of quarterly data

All positions including Celcuity held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celcuity by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 2.0M 1.34

More positions owned by OrbiMed Advisors

Boston Scientific Corporation (BSX)
Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)
Argenx Se Sponsored Adr (ARGX)
Sionna Therapeutics (SION)
Upstream Bio (UPB)
Disc Medicine (IRON)
Caris Life Sciences (CAI)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Celcuity

Linden Advisors
Baker Bros. Advisors
Ing Investment Management
D. E. Shaw & Co
Ameriprise Financial
Jump Financial
Lord, Abbett & Co
Readystate Asset Management
Sona Asset Management
Perceptive Advisors
Polygon Management
Millennium Management
Capstone Investment Advisors
SSI Investment Management
Affinity Asset Advisors

View all funds holding Celcuity